Ameriprise
OM icon

Ameriprise’s Outset Medical OM Stock Holding History

Ameriprise’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-120,682
Closed -$1.23M – 4137
2024
Q3 		$1.23M Sell
120,682
-225,995
-65% -$6.72M ﹤0.01% 3127
2024
Q2 		$20M Buy
346,677
+5,850
+2% +$287K 0.01% 1280
2024
Q1 		$11.3M Buy
340,827
+141,994
+71% +$7.19M ﹤0.01% 1681
2023
Q4 		$16.1M Buy
198,833
+82,143
+70% +$6.68M ﹤0.01% 1404
2023
Q3 		$19M Buy
116,690
+22,139
+23% +$5.23M 0.01% 1261
2023
Q2 		$31M Buy
94,551
+32,072
+51% +$9.78M 0.01% 1004
2023
Q1 		$17.2M Buy
62,479
+50,557
+424% +$18.6M 0.01% 1376
2022
Q4 		$4.62M Buy
11,922
+164
+1% +$46.2K ﹤0.01% 2341
2022
Q3 		$2.81M Sell
11,758
-177
-1% -$47.4K ﹤0.01% 2610
2022
Q2 		$2.66M Buy
11,935
+3,874
+48% +$1.67M ﹤0.01% 2693
2022
Q1 		$5.49M Sell
8,061
-50
-0.6% -$30.1K ﹤0.01% 2362
2021
Q4 		$5.61M Buy
8,111
+654
+9% +$484K ﹤0.01% 2387
2021
Q3 		$5.53M Buy
7,457
+1,092
+17% +$744K ﹤0.01% 2328
2021
Q2 		$4.77M Buy
6,365
+2,485
+64% +$1.9M ﹤0.01% 2483
2021
Q1 		$3.17M Buy
3,880
+354
+10% +$273K ﹤0.01% 2658
2020
Q4 		$3.01M Buy
3,526
+1,157
+49% +$892K ﹤0.01% 2586
2020
Q3 		$1.78M Buy
+2,369
New +$1.95M ﹤0.01% 2726

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ameriprise's OM Position: Q4 2024 in Review

Ameriprise sold out of Outset Medical (OM) in Q4 2024, closing a stake of 120,682 shares — an estimated $1.23M sold.

Ameriprise first reported a position in OM in Q3 2020 and held it in 17 quarters. The position peaked at $31M in Q2 2023. 73 funds tracked by Wall St. Rank hold OM as of Q4 2024.

  • Ameriprise reported no remaining Outset Medical position as of Q4 2024 after selling out during the quarter.
  • Ameriprise sold 120,682 Outset Medical shares in Q4 2024, an estimated $1.23M.
  • Ameriprise first reported a position in Outset Medical in Q3 2020 and held it in 17 quarters.
  • Ameriprise's Outset Medical position peaked at $31M in Q2 2023.
  • 73 funds tracked by Wall St. Rank held Outset Medical as of Q4 2024.

Based on Ameriprise's 13F filing for Q4 2024, filed 14 Feb 2025.